About Oncquest Laboratories Limited
Data last updated:
Oncquest Laboratories Limited is a public limited company based in New Delhi, Delhi, India, a subsidiary of Milky Investment & Trading Co. It operates in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 29 November 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24233DL2007PLC170898. Its GSTIN is 07AAACO9860B1ZI (Delhi). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹38 Cr and a paid-up capital of ₹38 Cr. It was formerly known as Oncquest Laboratories Private Limited. It is led by directors including Aditya Chand Burman and Rajiv Kapoor.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at First Floor Ashi 19 Rouse Avenue Institutional Area, New Delhi, Delhi, India – 110002.
As per the financials filed for FY 2025, the company reported a revenue of ₹97.99 Cr. For the same year it recorded a net loss of ₹40.75 Cr (net margin -41.6%) and EBITDA of -₹26.73 Cr (EBITDA margin -27.3%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 1% over five years.
The company has about 739 employees on its provident fund (EPFO) records.
The company is associated with 2 brands: Oncquest and Oncquest Laboratories. Court records list 12 cases involving the company, including 9 filed by the company and 3 filed against it; 7 cases are pending. The company has 7 deals on record (4 acquisitions, 1 funding round, 1 secondary share transfer), with disclosed funding of ₹55.96 Cr; the latest was in January 2025. Its 10 peer companies in the Healthcare industry (Diagnostics and Pathology Labs) are compared by revenue, 5 larger and 5 smaller; the largest is American Institute of Pathology and Laboratory Sciences Private Limited with revenue of ₹105.8 Cr. The company has 21 MSME Form 1 returns on record between 2019 and 2024, listing 11,261 overdue payments to 199 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website oncquest.net.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressFirst Floor Ashi 19 Rouse Avenue Institutional Area, New Delhi, Delhi, India – 110002
- IndustryHealthcare, Diagnostic Centers & Pathology Labs
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Oncquest Laboratories Limited
The main business activity of Oncquest Laboratories is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Oncquest Laboratories Limited FY 2025 filings available
Oncquest Laboratories Limited reported revenue of ₹97.99 Cr for FY 2025.
Compounded Annual Growth Rate (CAGR) of Oncquest Laboratories Limited
Revenue has grown at a compounded annual rate (CAGR) of 1% over five years. EBITDA rose 47% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Oncquest Laboratories Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹26.73 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹40.75 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Oncquest Laboratories Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -27.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -41.6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Oncquest Laboratories are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Oncquest Laboratories Limited
Oncquest Laboratories Limited is compared with the companies closest to it by revenue in the Healthcare industry (Diagnostics and Pathology Labs). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| American Institute of Pathology and Laboratory Sciences Private Limited | ₹105.8 Cr (FY 2025) | •••• | •••• | 14.0% | •••• | Hyderabad, Telangana, India |
| Hemogenomics Private Limited | ₹102.89 Cr (FY 2025) | •••• | •••• | 3.0% | •••• | Bangalore, Karnataka, India |
| Datar Cancer Genetics Private Limited | ₹102.27 Cr (FY 2025) | •••• | •••• | 31.0% | •••• | Nashik, Maharashtra, India |
| CRL Diagnostics Private Limited | ₹101.01 Cr (FY 2025) | •••• | •••• | 31.0% | •••• | New Delhi, Delhi, India |
| Lupin Diagnostics Limited | ₹98.57 Cr (FY 2025) | •••• | •••• | 42.0% | •••• | Mumbai, Maharashtra, India |
| Oncquest Laboratories Limited this company | ₹97.99 Cr (FY 2025) | •••• | •••• | •••• | New Delhi, Delhi, India | |
| Lucid Medical Diagnostics Private Limited | ₹94.91 Cr (FY 2025) | •••• | •••• | 2.0% | •••• | Hyderabad, Telangana, India |
| Accuprobe Healthcare and Diagnostics Private Limited | ₹94.78 Cr (FY 2025) | •••• | •••• | 35.0% | •••• | Delhi, India |
| Neuberg Ehrlich Laboratory Private Limited | ₹94.56 Cr (FY 2025) | •••• | •••• | -24.0% | •••• | Chennai, Tamil Nadu, India |
| Universal Medicap Limited | ₹91.31 Cr (FY 2025) | •••• | •••• | 18.0% | •••• | Vadodara, Gujarat, India |
| Konnect Imaging and Diagnostics Private Limited | ₹86.55 Cr (FY 2025) | •••• | •••• | 20.0% | •••• | Hyderabad, Telangana, India |
Peers are the five companies nearest above and the five nearest below Oncquest Laboratories by revenue in the Healthcare industry (Diagnostics and Pathology Labs), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Oncquest Laboratories Limited
Oncquest Laboratories Limited is audited by T R Chadha & Co LLP for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| T R Chadha & Co LLP | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Oncquest Laboratories Limited
Oncquest Laboratories has 4 current directors and 23 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Aditya Chand Burman Also directs: Dabur India Limited, Eveready Industries India Ltd, A.Cee Enterprises (A Private Company With Unlimited Liability) and 2 more | Director | 29 Nov 2007 | 18 Years 10 Months | Current |
| Rajiv Kapoor | Director | 23 Jan 2024 | 2 Years 8 Months | Current |
| Gaurav Chamaria Also directs: Blackburrow Agritech Private Limited, Dabur Pharmaceutical Ltd, Super Hoze Industries Private Limited and 5 more | Director | 26 Oct 2023 | 2 Years 11 Months | Current |
| Naresh Chander Arora | Director | 16 May 2025 | 1 Years 4 Months | Current |
Ownership and Shareholding of Oncquest Laboratories Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Oncquest Laboratories Limited
Oncquest Laboratories Limited does not have any charges (loans) registered with the Registrar of Companies.
Deals & Funding of Oncquest Laboratories Limited
Oncquest Laboratories Limited has 7 deals on record (4 acquisitions, 1 funding round, 1 secondary share transfer), with disclosed funding of ₹55.96 Cr; the latest was in January 2025.
Deals on record (5 of 7)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Aug 2023 | Acquisition | ₹146.47 Cr | Buyer: Burman Family Holdings |
| Mar 2022 | Acquisition | ₹23.83 Cr | Buyer: Burman Family Holdings |
| Mar 2014 | Acquisition | ₹33.83 Cr | Buyer: Burman Family Holdings |
| Dec 2011 | Funding round | ₹5 Cr | Investors: Burman Family Holdings |
| May 2009 | Secondary share transfer | Undisclosed | Buyer: Burman Family Holdings, Puran Associates Private Limited & Minnie Burman Seller: Puran Associates Private Limited & Shivani Burman, Puran Associates Private Limited & Aditya Burman, Puran Associates Private Limited & Sudha Burman |
Full deal history
All 7 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Oncquest Laboratories Limited
Oncquest Laboratories Limited has 12 court cases on record: 9 filed by Oncquest Laboratories, 3 filed against it. 7 cases are pending and 5 are disposed. Status as checked between 21 Sep 2026 and 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 7 | 1 | 2 |
| District courts | 5 | 2 | 5 |
Cases on record (5 of 12)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Arbitration matter | Filed by the company against Morestep Pathlabs Private Limited | Disposed |
| High Court of Delhi | Arbitration matter | Filed by the company against S-Dacc Health Care Private Limited | Disposed |
| High Court of Delhi | Arbitration matter | Filed by the company against Techizer Tech Solutions Private Limited | Disposed |
| High Court of Delhi | Arbitration matter | Filed by the company against an individual | Pending |
| District court, South, Delhi | Cheque dishonour complaint | Filed by the company against an individual | Pending |
Full case history
All 12 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Oncquest Laboratories Limited
Oncquest Laboratories Limited has 21 MSME Form 1 returns on record between 2019 and 2024, listing 11,261 overdue payments to 199 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 199)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | •••• | •••• | •••• |
| Credent Connect N Care Limited | •••• | •••• | •••• |
| Goodwill Diagnostics | •••• | •••• | •••• |
| Solution One | •••• | •••• | •••• |
| Embee Diagnostics Private Limited | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 21 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Associated Brands with Oncquest Laboratories Limited
Oncquest Laboratories operates two associated brands: Oncquest and Oncquest Laboratories. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Operates a chain of pathology laboratory centers providing diagnostic services. | oncquestlabs.com | |
| Chain of diagnostic labs | oncquest.net |
Employees and EPFO Compliance at Oncquest Laboratories Limited
Oncquest Laboratories Limited has a workforce of 739 employees as of Nov 08, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Group Structure of Oncquest Laboratories Limited
Oncquest Laboratories has 1 associated company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
CIN History of Oncquest Laboratories Limited
Oncquest Laboratories has one previous CIN (Corporate Identification Number): U24233DL2007PTC170898. The current CIN is U24233DL2007PLC170898, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24233DL2007PLC170898 | Current |
| U24233DL2007PTC170898 | Previous |
News related to Oncquest Laboratories Limited
Recent Activity on Oncquest Laboratories Limited
Oncquest Laboratories Limited has 25 board changes on record since 2007: 6 appointments and 19 cessations. The latest: Naresh Chander Arora ceased to be Additional Director on 28 Sep 2025.
16 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Oncquest Laboratories Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Oncquest Laboratories Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Oncquest Laboratories Limited
Oncquest Laboratories has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAACO9860B1ZI | Delhi | Active | 01 Jul 2017 |
| 06AAACO9860B1ZK | Haryana | Active | 24 Feb 2022 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Oncquest Laboratories Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Oncquest Laboratories Limited
Oncquest Laboratories is an active public limited company based in New Delhi, Delhi, India. The company works in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 29 November 2007 (19+ years old) and is registered under CIN U24233DL2007PLC170898.
Oncquest Laboratories reported revenue of ₹97.99 Cr for FY 2025.
Oncquest Laboratories has 4 current directors:
- Aditya Chand Burman - Director
- Rajiv Kapoor - Director
- Gaurav Chamaria - Director
- Naresh Chander Arora - Director
Oncquest Laboratories reported a net loss of ₹40.75 Cr (net margin -41.6%) and EBITDA of -₹26.73 Cr (EBITDA margin -27.3%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Oncquest Laboratories is 2% over three years and 1% over five years. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Oncquest Laboratories is 07AAACO9860B1ZI, registered in Delhi. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 06AAACO9860B1ZK (Haryana).
The CIN (Corporate Identification Number) of Oncquest Laboratories is U24233DL2007PLC170898. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Oncquest Laboratories has 12 court cases on record: 9 filed by the company and 3 filed against it. 7 are pending. Most are in the high courts.
Oncquest Laboratories was incorporated on 29 November 2007, making it 19+ years old. It is registered with the Registrar of Companies, Delhi.
Oncquest Laboratories has 7 deals on record (4 acquisitions, 1 funding round, 1 secondary share transfer), with disclosed funding of ₹55.96 Cr; the latest was in January 2025.
The peers of Oncquest Laboratories by revenue are American Institute of Pathology and Laboratory Sciences Private Limited, Hemogenomics Private Limited, Datar Cancer Genetics Private Limited, CRL Diagnostics Private Limited, Lupin Diagnostics Limited and 5 more, all in the Healthcare industry (Diagnostics and Pathology Labs).
Naresh Chander Arora ceased to be Additional Director on 28 Sep 2025. Prashant Kumar Balodia ceased to be Additional Director on 10 Jul 2025. Naresh Chander Arora was appointed as Director on 16 May 2025. Oncquest Laboratories has 25 board changes on record in total.